Compound ID | 1261

DA-7310

Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)

Spectrum of activity: Gram-negative
Details of activity: Activity against Gram-negative pathogens including multidrug resistant.
Institute where first reported: Dong-A ST Pharm
Highest developmental phase: Preclinical
Development status: Active

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.